title: Emerging anticoagulant drugs.
abstract: The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.
authors.affiliation: Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Shannon M
authors.initials: SM
authors.lastname: Bates
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000493:pharmacokinetics / Q000494:pharmacology; D000075202:Contraindications; D006801:Humans
chemical_list: D000925:Anticoagulants